NHS to End Partnership with US Spy-Tech Firm Palantir

A Shift in Data Security Priorities

Andy Burnham, the UK's prime minister-in-waiting, is set to end the National Health Service's (NHS) contract with US tech company Palantir. This decision comes after Burnham was mayor of Greater Manchester, where the council issued no contracts to Palantir.

The NHS has been working with Palantir since 2020, using its data analytics software to help manage the pandemic. However, Burnham's move to end the partnership has sparked concerns about the potential risks of relying on a foreign company for sensitive data.

Can the NHS Afford to Lose Palantir?

Palantir's data analytics software has been at the center of controversy in recent years, with critics accusing the company of collecting and selling sensitive data. The NHS has used Palantir's software to track COVID-19 cases and hospital admissions, but Burnham's decision to end the partnership raises questions about the future of data security in the NHS.

Burnham's decision to end the partnership with Palantir is seen as a significant shift in data security priorities. As the UK's prime minister-in-waiting, Burnham will be responsible for overseeing the country's data protection laws and ensuring that sensitive data is handled securely.

Frequently Asked Questions

The NHS has invested heavily in Palantir's software, and ending the partnership may require significant investment in new data analytics systems. However, Burnham's office has stated that the NHS will continue to prioritize data security and transparency, even if it means investing in new technology.

The decision to end the partnership with Palantir has sparked concerns about the potential consequences for the NHS. Will the NHS be able to find alternative data analytics solutions that meet its needs? And what does this decision say about the UK's approach to data security?